Showing results (61-70 of 78) with videos related to
Sort By:
Pageof 8
Research Square|March 24, 2021
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIVAljawharah Alrubayyi, Ester Gea-Mallorquí, Emma Touizer, et al.Nature Communications|October 6, 2021
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIVAljawharah Alrubayyi, Ester Gea-Mallorquí, Emma Touizer, et al.Journal of Translational Medicine|April 17, 2015
A human immune data-informed vaccine concept elicits strong and broad T-cell specificities associated with HIV-1 control in mice and macaquesBeatriz Mothe, Xintao Hu, Anuska Llano, et al.Biorxiv : the Preprint Server for Biology|February 23, 2021
Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIVAljawharah Alrubayyi, Ester Gea-Mallorquí, Emma Touizer, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2025
A Phase 1b/2, Randomised, Placebo-controlled Study to Evaluate Safety, Tolerability, Efficacy, and Immunogenicity of VTP-200, a Chimpanzee Adenovirus and Modified Vaccinia Ankara-vectored Multigenotype High-Risk Human Papillomavirus Vaccine in Women with Low-grade Cervical LesionsKarin Hellner, Philippe Simon, Philippe De Sutter, et al.Frontiers in Immunology|February 5, 2019
A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV CoinfectionFelicity Hartnell, Anthony Brown, Stefania Capone, et al.Journal of Virology|April 28, 2006
Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopesNilu Goonetilleke, Stephen Moore, Len Dally, et al.Eclinicalmedicine|January 21, 2020
Corrigendum to 'Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)' EClinicalMedicine 11 (2019) 65-80Beatriz Mothe, Christian Manzardo, Alvaro Sanchez-Bernabeu, et al.Eclinicalmedicine|July 18, 2019
Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study)Beatriz Mothe, Christian Manzardo, Alvaro Sanchez-Bernabeu, et al.Lancet (London, England)|February 23, 2020
Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trialSarah Fidler, Wolfgang Stöhr, Matt Pace, et al.Pageof 8